triiodothyronine has been researched along with Coronavirus Infections in 4 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Coronavirus Infections: Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support), ClinicalTrials." | 2.94 | Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. ( Armaganidis, A; Kostopanagiotou, G; Mourouzis, I; Pantos, C; Trikas, A; Tseti, I, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pantos, C | 2 |
| Tseti, I | 2 |
| Mourouzis, I | 2 |
| Brancatella, A | 1 |
| Ricci, D | 1 |
| Viola, N | 1 |
| Sgrò, D | 1 |
| Santini, F | 1 |
| Latrofa, F | 1 |
| Kostopanagiotou, G | 1 |
| Armaganidis, A | 1 |
| Trikas, A | 1 |
| Assimakopoulos, SF | 1 |
| Markantes, GK | 1 |
| Papageorgiou, D | 1 |
| Mamali, I | 1 |
| Markou, KB | 1 |
| Marangos, M | 1 |
| Michalaki, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer[NCT04659200] | 20 participants (Actual) | Observational | 2020-09-01 | Completed | |||
| Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support)[NCT04348513] | Phase 2 | 5 participants (Actual) | Interventional | 2020-05-29 | Terminated (stopped due to Due to specific inclusion criteria no more subjects could be enrolled.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for triiodothyronine and Coronavirus Infections
| Article | Year |
|---|---|
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Coronavirus Infections; COVID-19; COVID | 2020 |
3 other studies available for triiodothyronine and Coronavirus Infections
| Article | Year |
|---|---|
Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Humans; Pandemics; Pneumonia, V | 2020 |
Subacute Thyroiditis After Sars-COV-2 Infection.
Topics: Adolescent; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID | 2020 |
Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of "non-thyroidal illness syndrome"?
Topics: Aged; Biomarkers; Coronavirus Infections; COVID-19; Euthyroid Sick Syndromes; Female; Ferritins; Hum | 2021 |